The Growing Challenge of Antimicrobial Resistance

Antimicrobial resistance (AMR) continues to be a major global healthcare challenge as bacteria become increasingly resistant to antibiotics used to treat infections.

AMR Awareness Week highlights the importance of improving antibiotic stewardship and developing technologies that support more targeted treatment decisions.

At Inbiome, the focus remains on how faster and more accurate diagnostics can contribute to smarter antibiotic use.

DARTBAC Meeting Focuses on Faster Diagnostics

During the recent DARTBAC meeting, Inbiome R&D lead Martine Bos joined researchers and clinicians working on advancing orthopaedic infection diagnostics.

Charles Vogely presented on the past and present of orthopaedic infection treatment, emphasizing the continued need for faster diagnostic workflows in clinical practice.

Molecular Culture Detects Pathogens Missed by Routine Culture

Elizabeth Morreel presented new findings evaluating Molecular Culture in joint sonicates, fluids collected from prosthetic joints during diagnostic procedures.

The results showed that Molecular Culture detected a broader range of pathogens than conventional culture methods and remained effective even after prior antibiotic treatment.

Pathogens including S. aureus and Streptococci were still detected in culture-negative samples, highlighting the potential added value of molecular diagnostics in difficult infection settings.

Supporting the Future of Infection Diagnostics

As antimicrobial resistance continues to increase globally, molecular diagnostics are receiving growing attention for their ability to support faster pathogen identification and more targeted antimicrobial therapy.

Inbiome stated that participation in the DARTBAC consortium reflects its continued involvement in advancing diagnostic science and improving infectious disease workflows.